Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Biofourmis
AddedFeb 19, 2024
UpdatedJun 18, 2026
Biofourmis

Biofourmis

Series D

Biofourmis Pte Ltd: A digital health firm offering physiology-based health analytics via m-health devices, serving Singapore & South Africa.

HQ
Boston, MA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded in Singapore, Biofourmis is a digital health company dedicated to revolutionizing healthcare through advanced health analytics. The company's core mission is to leverage human physiology and digital m-health devices to capture and analyze clinical information, ultimately improving patient outcomes. Biofourmis offers a comprehensive health analytics platform that integrates bio-sensors and software solutions, serving markets in Singapore and South Africa.

Notable figures affiliated with Biofourmis include its founders and key investors from prominent venture capital firms. The company has achieved significant milestones, such as securing substantial funding rounds and forming strategic partnerships with leading healthcare providers. Biofourmis has made a considerable impact on the digital health landscape by enhancing remote patient monitoring and personalized care, thereby setting new standards in health analytics and patient management.

Biofourmis - Similar Companies

Heads Up Health logo

Heads Up Health

headsuphealth.com

BioTrillion logo

BioTrillion

biotrillion.com

InSyBio logo

InSyBio

insybio.gr

Biobot Analytics logo

Biobot Analytics

biobot.io

Bioinformatics logo

Bioinformatics

bioinfoinc.com

Profusa logo

Profusa

profusa.com

BioSignal Analytics logo

BioSignal Analytics

Twin Health logo

Twin Health

twinhealth.com

The Public Health Company logo

The Public Health Company

Flow Health logo

Flow Health

flowhealth.com

BioHealthonomics logo

BioHealthonomics

BioscanR logo

BioscanR

4D Healthware logo

4D Healthware

4dhealthware.com

Health Vector logo

Health Vector

healthvector.world

Insightiv Technologies logo

Insightiv Technologies

Biofourmis - Quick Facts

Who are Biofourmis' competitors?

Companies similar to Biofourmis include Heads Up Health, BioTrillion, InSyBio and Biobot Analytics.

When was Biofourmis founded?

Biofourmis was founded in 2015.

Where is Biofourmis' headquarters located?

Biofourmis' headquarters is located in Boston, MA, US.

When was Biofourmis' last funding round?

Biofourmis' most recent funding round was for $20M (USD) in July 2022.

How much has Biofourmis raised to-date?

As of Jul 27, 2022, Biofourmis has raised a total of $463.6M (USD).

How many employees does Biofourmis have?

Biofourmis has 375 employees as of Feb 4, 2024.

Biofourmis - Classification

Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • Asia
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Health Analytics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software